Pfizer Inc (PFE)
26.62
+0.06
(+0.23%)
USD |
NYSE |
Dec 27, 16:00
26.57
-0.05
(-0.19%)
After-Hours: 20:00
Pfizer SG&A Expense (Quarterly): 3.244B for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amgen Inc | 1.625B |
| Gilead Sciences Inc | 1.433B |
| Regeneron Pharmaceuticals Inc | 714.40M |
| Viking Therapeutics Inc | 13.77M |
| Moderna Inc | 281.00M |